CLINICAL TRIALS

We Embrace Innovative Approaches to Clinical Development

Our clinical investigation programs focus on innovations that have the potential to deliver highly impactful therapies for  serious liver diseases and potentially bring differentiated therapeutic benefits to patients.

 
 

ONGOING CLINICAL TRIALS

 

Phase 2 Study Evaluating BOS-580 in Patients with NAFLD and/or NASH

Status: Active
Study ID #:  NCT04880031